Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

5 Facts About Sexual Dysfunction in Women and How to Get Help

photo

SPONSORED CONTENT -- (StatePoint) Forty-two percent of women experience sexual dysfunction -- and Hypoactive Sexual Desire Disorder (HSDD) -- characterized as frustrating low libido, is the most common form of it. It is estimated that about one in 10 women have this condition.

The good news? Low sex drive in women can be treated. Clinically proven options are helping hundreds of thousands of women address HSDD. In fact, as of May 2025, over 25,000 healthcare providers are prescribing Addyi, a particularly effective hormone-free drug sometimes referred to as “female Viagra” or “the little pink pill.” Here are five facts to know about HSDD and how medication can help treat it:

1. HSDD is caused by an imbalance of chemicals in the brain and its effects can extend well beyond the bedroom. HSDD can also cause feelings of frustration and create tension in relationships.

2. For the last 10 years, Addyi has been the number one prescribed treatment for HSDD in women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.

3. While many prescription drugs are unaffordable, Addyi is often covered by insurance and can cost as low as $20 a month.

4. Addyi is well-tested. Sprout Pharmaceuticals conducted the largest ever clinical trials in women’s health for its FDA filing, submitting evidence from over 13,000 patients, three times as much data as any male sexual health drug. In pooled data from three pivotal trials, Addyi significantly outperformed the placebo across all six Female Sexual Function Index domains: orgasm, lubrication, arousal, desire, satisfaction, pain reduction, as well as met all measurements of effectiveness required by the FDA with statistical significance. The results:

• 50% increase in desire for sex

• 75% increase in satisfaction with sexual events

• 50% reduction in the stress women struggling with HSDD feel

5. Wide-ranging organizations see the value of this medication for women’s health and well-being and supported its FDA approval, including The National Council of Women’s Organizations, the Black Women’s Health Imperative, the Association of Reproductive Health Professionals, National Consumers League, and the American Sexual Health Association.

You can find out if you’re a good candidate for treating HSDD with medication by bringing it up with your existing healthcare professional. To find a provider in your area, to learn more, or to access Addyi via telehealth, visit https://addyi.com.

“Living with HSDD can be challenging. Fortunately, the regulations around drugs that can help women address their concerns around sexual function have caught up with the need,” says Cindy Eckert, founder and CEO of Addyi.

Photo Credit: (c) PeopleImages / iStock via Getty Images Plus

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.